Equity (Tables)

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

Schedule of Stockholders' Equity Note, Warrants or Rights

	Number of Warrants
	Equity  classified	Liability classified	Total	Weighted average exercise price
Outstanding at December 31, 2020	292,469	12,085,547	12,378,016	$	1.60
Exercises	—	(1,642,036)	(1,642,036)	1.46
Outstanding at December 31, 2021	292,469	10,443,511	10,735,980	$	1.62
Issuance	—	20,571,429	20,571,429	1.55
Canceled	(79,130)	—	(79,130)	17.71
Reclassification of warrant liability to equity on modification	2,022,987	(2,022,987)	—	$	1.46
Outstanding at December 31, 2022	2,236,326	28,991,953	31,228,279	$	1.53

Schedule of Authorized Shares of Common Stock for Future Issuance

The Company has authorized shares of common stock for future issuance as follows:

	As of
	December 31, 2022	December 31, 2021
Exercise of warrants	31,228,279	10,735,980
Shares available for future stock incentive awards	5,782,591	6,039,564
Unvested restricted stock units	1,705,558	394,450
Outstanding common stock options	15,844,651	11,039,873
Total	54,561,079	28,209,867